Use of a rare disease registry for establishing phenotypic classification of previously unassigned <i>GLA</i> variants: a consensus classification system by a multispecialty Fabry disease genotype–phenotype workgroup
Dominique P. Germain(Université de Versailles Saint-Quentin-en-Yvelines), David G. Warnock(University of Alabama at Birmingham), Robert J. Hopkin(Cincinnati Children's Hospital Medical Center), João Paulo Oliveira(Universidade do Porto), Christoph Wanner(University of Würzburg), Roberta Lemay(Sanofi (United States)), Juan Politei(Ofcom), William R. Wilcox(Emory University), Daniel G. Bichet(Hôpital du Sacré-Cœur de Montréal), Han‐Wook Yoo(CHA University Bundang Medical Center)
Cited by 66
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Fabry disease
|Orphanet Journal of Rare Diseases|2010|1.2k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990